Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Brugada syndrome].

J Brugada1, R Brugada, P Brugada

  • 1Institut cardiovasculaire, Hôpital clinic, université de Barcelone, Espagne.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|August 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IMPACT OF RADIOFREQUENCY CATHETER ABLATION ON HEALTH-RELATED QUALITY OF LIFE ASSESSED BY THE SF-36 QUESTIONNAIRE IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA.

Georgian medical news·2018
Same author

INFLUENCE OF CATHETER ABLATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ON PATIENTS' ANXIETY.

Georgian medical news·2018
Same author

Clinical News.

British journal of hospital medicine (London, England : 2005)·2018
Same author

[Hypothermia-induced ECG changes: characteristic, but not specific].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017
Same author

ANXIETY LEVELS IN PATIENTS WITH PAROXY-SMAL SUPRAVENTRICULAR TACHYCARDIA IN RELATION WITH THE PATIENT DEMOGRAPHICS, TYPE OF SUPRAVENTRICULAR TACHYCARDIA AND THEIR PERSONALITY TYPE.

Georgian medical news·2017
Same author

Only a boost away from re-entry.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2017
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

This genetic heart condition causes sudden death in individuals with normal hearts, identified by a specific ECG pattern. Early diagnosis and implantable cardioverter-defibrillators are crucial for survival.

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Context:

  • A genetic syndrome characterized by syncopal episodes and sudden cardiac death in patients with structurally normal hearts.
  • The condition presents with a distinct electrocardiogram (ECG) pattern resembling right bundle branch block with ST segment elevation in leads V1-V3.
  • Genetically determined with autosomal dominant transmission, linked to mutations in the SCN5A sodium channel gene.

Purpose:

  • To review the clinical presentation, genetic basis, diagnosis, and management of this specific cardiac syndrome.
  • To highlight the diagnostic challenges posed by concealed and intermittent forms of the disease.
  • To discuss the prognostic implications and current treatment strategies, including the role of implantable cardioverter-defibrillators.

Summary:

Related Experiment Videos

  • The syndrome, linked to SCN5A sodium channel mutations, causes significant sudden cardiac death rates (4-10 per 10,000) in certain populations.
  • Diagnosis is primarily ECG-based but can be challenging due to intermittent or concealed forms.
  • Pharmacological agents like ajmaline, flecainide, or procainamide can unmask the condition, while beta-adrenergic stimulation may normalize the ECG.

Impact:

  • This condition accounts for a substantial proportion of sudden deaths in individuals with structurally normal hearts.
  • Effective diagnosis and timely intervention with implantable cardioverter-defibrillators are critical for improving patient prognosis.
  • Standard antiarrhythmic drugs like amiodarone or beta-blockers are ineffective in preventing sudden death in affected individuals.